Indication :

• advanced ovarian carcinoma
• small cell and non small cell carcinoma of the lung
• squamous cell carcinoma of the head and neck
• advanced transitional cell carcinoma of the bladder
• significant responses have been observed when KEMOBOTIN® employed in the treatment of carcinoma of the cervix.

KEMOBOTIN® is frequently used in combination with other chemotherapeutic agent in various indications, such as with paclitaxel in first line therapy of ovarian carcinoma and non small cell lung cancer.

Compositions :

Each mL contain Carboplatin 10 mg

Storage Condition :

Store 2-8°C, protect from direct sunlight, do not freeze.

Shelf Life :

24 months